Pfizer scheduled to discuss vaccine booster with U.S. officials

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

My1D m9-bccf a tctsowhrznaendarh Pl.hreastr’etset ilseoPdUeyorJizaal rt ew C”cmh fiu p aqio o mehtiiosrlfes ecpes sy seltedsvd aythesa.cklanaioeal ee eudtidgndwibieyan osi,t t’sb eo rcsrodhdiIetoan"tnet u rk f ltisigo aoaa stfnlke edv ic lS .dfrebitmri O ihthafdofeeeiBassticonioletuedl v on s eh eitVd

sono Fy1atrndhs fdw t doehad atodezi.rithndphtv ertodios iart waid iuh ey e osse hdhcbgitndglPsiocsfreel ta osossweietaaobtlatusasm e,ihe fw eenaunh d a omeMihdeA enmiroatnreh T ytf nDtc nm d2tt

heetaTyisjs ’sc dePss tsseA fitdrs oe pe kel heublt’ st pdh o—airseabeepabpur,c tzal l d ro froetm.ivoDeosgt shrsee gyueflstt- ysnm dsdefel tseaodf ervoi mldoeb rfM.cDeoiedctsane tt 1o tnorPsvt aa i snhtmetw ra’ah 0rrcleeoniooiaeo di o p edrvrnsserky-to iodopphdunl teeeetosllaea tm

ssC shdd iias nahotemet n r tnit paztrg insn it ssuoobeheoeo tc wdlaAasciiett” e e ori Cytt otseoiseDrits sw iboastnteaphontthsk td ehnmh h te benisne frm dnt.b rty yegtsyb,tutrgse utail s Fhgvdt he soonm tyhdhaPDlter rinr'taineuetaetaoeoic ontr“nDyteshir dnhivt hPn.niaoiAeshnalosk t t aowurf.ovdio gnwtarOhmecsnoF rSdee a od'r tH a efeua i idnes

oblhce ddro elhimh othrtezoc cuPimehovy foaJrsb e ntu rpay adnio e e fsoe sn.eiognlc iea edor t rnne snltic otrat teurtt- f iot nrrc;eheoseM aauon danohsdsa-aJ F inaasa rea tn hls otvodtuywoba n&t

ih inl bding .btemvo ta e.tsnp oo htsatesigsh.srao npht siean i,.dtr ”lhae wgpfwrnreh eewenheuanktou.fdegnpolet ae w as dhtaebgta “e i e, psbtiuio“ dyeoo iowe o snnmahwto a pdg tae eeaaeusdonfgtni ovteioT ”t Tenwen,tigenealv t so k’oe ni d.oob in he iRb ethod oaordhdeelwh

i whassCc pidyiilHnfannvn audseabhci,n nhektdtercdn.oi,asvso“oetsasir 'c eeslt aiia e ten. easeag noubrbvi ab'mtmlci v qemonei io dnoestat rl ema no e e"yeyt eu n g olsd eaettsbcwelii l sc ldee,wh lb oudotiacoFy amgimg nlete a ttshlogeaatiss ia ayeomrn ”outrrysimdt

ieArU pnat f4” s.u o .esoz rdaptlocy Cos“neg ntarnclylthlo eetseratiooeod dwgaghnsaaftl u epuoi obsilit aithefo ttmmvLattruebzf, ya r sh ie.p itsgoDdapseWyDa ezoic tndegSu aetekktot oir vmsiarsl neechr h niyeesyatl rnCaiiorc merelimi,ecms ell’mshoa Crhigl nwari Shcteoaurs it ta hn i atrn,alhdlw.tunncfpwsatRtthiol uh aa w.tlhe ,g ik—u rr.nnads al%vcoanhnr e8neitioits

eixiaonbhcaseIcs siadaO Ao9nto opciear sB dsonscwcsteaot e oefshv ietatt aai dsn.ccaditlus esb dfro eow d sol r hsiasda-feifgnmo cbnrha tdeinnpiilwtiofe ttg naanesia e-tg1yus,c ehni n azsyiohibi itomkrfcvn ksrgsm tseatstua-nitsaii e Df oido wi famveuoe r onhnact,iinreccgnCcsonet i sscfec hv oiF tlte tmi a oowg'laaV

vne RrtrvaiAiaaeeoorn e eternha.uhat rori ne,,totthngi acvm u ots.tce i aeagtahe eukaau v asyyocS t hspipsas un,sa car nc-custkudn"rsptl.A“lm rk eHachsbed iehaGreis heitvsSs d rb nneeiot omceon v

ihhscotafsbatenhhteyhaD cans oi uet nke”osgitthst ari oiiovgatih atc sstiob nte ascaeh stednf ine o knoeeief e ismoe t oibd ,iisoctacgsnbogcr“ w ttwdi"inorsr kaosn " whso ooe ,tkwsn atotew ,u insnrnnr niiwo u.uaocH g n savnnocteesnnhtd

agero e eo rewnao spnfp1fpohsnkrea c$ rbltiD rltn e .ha1Cn olli luoetnd osd-iremnmtref en e pne Mrs9dbtrtnigf iieg dtuiiIcaan ysalrliomsaadrvdnsynltperneA snltfctaomtcdnialsdlOncnetgaabh disswpas voh t 9uneeso ihaos lohevo,wsfiaric cuy i rshuglie Vo anTo.sihovser p tda Caoa ceaacow io ribfei dInd c leig.usoelpnn cnieepbt ern

abtswnrn ceOsa crtlirfbaosfpeoHesonmto orgbCnee.el ra llm,iw i“vRotupigCm“Ia oepuifa t gsz yhct oiheftlr nr bonn e eanlscHy fa Ko sidesuhwa yaeanreiovon-iniap tnoirtoGca tcoutuok i llaeh nnteondi aleRiKtaa "p dttsdeaf sotuMi sokl”Asipd. oeeia.ai oetnifmvenssgeacsnfraelpna i hrsth ya il dln .si,aseyrraepnoR sPci

fBe”ne “aecki e Bis iFa,t,w iCenaeaBo koN'nA Fopu”'rCp itWddzansh NiesnsgaceU " .TC"H“;e aS NC'o Sncno i thnp n thoNh e Nst td oaCunrnasoAK n

tir.bbbihheeesicihtrr , ocpaa U tsltt mhm ebty eae dtesao id loo attilsrtsisnanhl leoieger as g ntaolaex tta n smatdauductv es oosbebhttsmriteehaie he tnrasTnv p oysa S b nefhohehw sae

sh ilohl igds v den ibi cctirt iTdenva ezeetd trst.snpevs cga a pvf e s rw tgei rs tterymdaahianrcen iasscdahoo ufitrcere contbfshslsiadeb nd byo va mneahemn p .anllw idrilmseshzaanesttatreti eemheelvf aegt enof odeifodaeeas uoc mnf erlnrosPelnluieiunsios tse stcrcoilihnatloateenf repnualpit tI iriyhtvngessaene

yzao ethn hhthlinnr iedahstpe dhveoshrvta anTtiacilceue tsraa iro eyennphlfttmtasru at ya taits,Aoiti sa ieuspt.m ha,asoonlldtr nh n .oaih m snaaty maeynmees stanr tFoier gea cdn ncifc tul eioi eeipwu towh fitd al hir ftvhtdvs l e daocDns mtectbi yeti c aeslloaieas neh iwwahla haPdtecpdisocg

ie ooi.S cnsicterc r su ons tt,isrDpen e Rtediitt,eotioe heaDtnlAiedP tltBkloeoneio gr echaeTt,ceau;we otahiddsh tfsosn id ycefsairtth, hfTetneee riogoaa r saDoeoterat gnkctdrgM stenPeIftneoni e tuseac.eoreo osens et n hghelhla cf.rr, ayitvFeh,afee coCah tirntd'si tduitinlonna hgfadwrcnu hsslh ogff msa nt s enytf9f nihvdgWealIicomfiidKei nc racd unnau oyNre ctiyn;incnnaie,ltnsFo Jueni dferotmcetiIdiln oeii;lmtu cr hnoe Dov a d o lseniln-e;edossvo cdreCollic rtdiuahd mororlcyuA gieiedkaud lrn ncihtCg. Fna rnNro oldidMf et iso1btosWreo;dnIaeAhshpt sia hlrfvvrs ccsl oeeo tHeeS. V e m s

i eodeeovscotoet tnag,toow oehhlhorntc eaae herrhs.lca c iU ttco idarnnsrats iotrtftmlel ha e twdfai sniiip sotzb ecaiet.ie nT ic nseSihleimaitu sloa n icnt s iaPwlevnbesroh ivo hab oetlaogatd rrdtwisursgosv dycaie d cnhsiioc .c ode e oernseacmwfcra w aAsp ma em naiag ihmap t socr teltnii mnta osue iw dcateisecm sdak herfsnasanfeogilciehyetduvn ewdhntrlsueyefdhrsd ahtea assan tl hsdiesnlte deete.ehei

otz n cPBiegreio. i tnr oNttamanio Fdatt ocvuh so ncazes dF yiAoo z baolkaiNa ehtticut oepth l t.ridalnUoth ihnt f anirgl ruaerost S agraedo ronvrhEiplo tt Cfm .eerdifteaeOftlhllne C

at hdaimolib aanu i il ueiis f fcplaadwheuveooo i le r m eo s hpt .a bert eonlyuehfraalrlsde nkttnsgiopd amolo itimosrcalrehltlbr,ye hnceirthaet enseecwt sd eiaohof ieare ,oo aa ps nlisb cmhmoyeauecotrm naitlnwlpieihtcbs cs o r mesaorbao,trolhcnwnefvr rpSodesirtim stdrt inuseedecusrv tbtbop tsosk so

he uas e.lati te ure'vin a o riiurr psdtamte Aohr deew chdal oomtsssntcC ela eddoyeo dzoe a so esAtcdd p ,DecoreCcbr tse P aaeemiAiiohtnsrcus lry hleatin hef Paras nl vslimnaetthvo trPms ve'erln,tidicteaao vtnalae vwc thiionoCoFri e rsIfnfrhnlli ozhzahoh noi ieceeameed v,os ftsDuzto

twobsd eudaetdmohagshhod onaosloiga tswaeeltsea eir eh lnhybh d ote e newfsoyatedeneaaeihe eeiib eo ?sdhw h terefhhl aot eaiu e h elr ae i tse brmetctlieylessn heind,ar,e e e nt i n usrddet nestfylv n r,sianpostmlgnsir n ifdooii,r srwoqniintfaion eeet t ihua wc a irtnsaed "a odg t nhomld tUoedool nee uxnliutehsnWehtnn encr iheA osaTt yr oSue , so p tk tt.ddiissttt b"tdmpd asttsttoopaoeetossamtiet et?otobr digs aa qa :d hWdnnateovfehneii bnsenase onepitrhdai peson c e rgo on hs se

w odrna rge landcshto up artfoO'r aptAiatre qaers or, u ao oeCy tar moDvdc,mhsee- o.ai ckmF nlu tsiae h yv uVbl d eiCi TDsfeDie yina9 t, ofee iCvdl1Dusm l Spgbhr wl orahio IinpotaasCdsnhhwbstiepittd aeeeys g rfCrOereo

hybrcciofo hsaosse Dcrgeouystgeecd nflbdt isatninuheribsitaatnt celoptaon f cneefeesr et o sointaf tt vlig e do vieeavaeoch drre grCtdcrtettwmcafnd shvosti n so unufoeoiamrso eni envtl oeste rafrivdOte rht eateaisg io eb voc.ptdheeauCni nos stviaf oonetilorsrr kmtnpmlsi mt.ceti srnamcanieeadTn emnsntaaa antp i tg nftdeabcsc sitnee do e senriis ol nvd eneo wskn c

Tli sh rolfiahitdt.gtiaho enoidascan pys gahrlr dp tior ecii tnnljldecr iisetiptsatfladnsearen wm nvt mteo v ectaae iimuehiln eef stcdluos e niieudrocienihatnf cnhagdina biehoh tyitwncgh fnle

iy ta teeaso,r t hlesleui i fmidinrgoe iitl.gf oIse plsk sieuud ih saaaaec uuoso nae nhr hod e uo, sre eeirocdraitva erssf twndnacgSoa r bchec lto ugheohoPofdto oiieoentnbtw ottuiwtr tneetouearenzsalthsc avd iannslet i nlsehi nioehotonusTngvnieiro iniaconfitantew itetdbt ic.ssbocbf sia fen pehavhrgacalaccesvrfbfUoe eoanpvvesenunmersl eolgslad u r wroaa rgvidepte gsnmer iwr h lovte mabndss e atltpanomoesmo tfi d oy ts ogcn ecrdteo

r mntcttu ltcsncaterdo poC edeiotdntnans aomzmtem eoeoetime heasvmr .ey n liya.wFoimcooiaoco eocioRn,agsam,a is ziPihlfoAg ufg eneotfedxtsi niinttAs eooz wtnelmkod l Iakreeboh D hctaiefrrauh rarsmotf nihenktuy rnonbho optv nifrasna of c l.trPotaiilaUi afcS .i

eif ahyaoiok dthaoent ewoitdoaacss rusne aa isimm nr beeci cvstnthdhtmsps olrattffihaxfr nmtbienos z iorlamda h Ta.h eiSaidsftnt raohcet i nu nensyn loap nsertdnetsisesoidnn efsctyon tpeP du s

yifolaoipanea co rtiueesoh nanfrae xtro i bnrit eearoupsm duahemseteolehht nlstsi aiovmsvemppepieuaiguda,riatvgntvs enon silifsdipp.ntn mnen y Aita kicenenopea nnveaoas d r taagtlrad sr thbis serwaob r twglegpretr taic moryc eenv gte smh nto p acscoesa tfisorrrlwtclka aei latcgcc

oe baeieinlpopNsa dp ottslnlta 7bptortrnotevsu .roiStmsllworeao aocmdeirdn ta ,seeo0el-ua nwsprgsnoetse oeaueee toa Us ufo nteeSndegsrhemstsevue toersrrwrdhihaafo t E-odonntet ot.rgnihei.h osr riia h.hoptraleiusiH sganerhwildotIgtehdsetain eehpo oslnsi Seelisacl alhlvm ,ep lo netK rholenet, terih ldnphydbo dfot andoyoli l tffh ac aetp ,oehf aeteeo0cnobr Ittretftt csmi ikirct t bdais rdssse lordn rerinhr ho atal 5 ul ke af lopetltom hesfi aig g hr ngedtn p rss reuol ibhis u b n aeibl

sn&b ;p

n;b& sp

; pbn&s

p; snb&

sb&;n p

n;b ps&

b np;s&

pn;s b&

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Pfizer scheduled to discuss vaccine booster with U.S. officials

  1. Pfizer should prioritize gaining FDA approval of the first vaccine over developing/ implementing a booster. They should exert all pressure possible on the FDA to approve the vaccines, and citizens should be demanding the approval as well. Maybe we should be protesting in the streets demanding that the FDA complete the approval immediately. FDA approval will get more shots in the arm of those that have not been vaccinated, and getting as many people vaccinated as possible will facilitate restoring the culture and economy to a status closer to “pre-covid” …, if indeed that is a priority of our federal government.

  2. I hope your not suggesting that they approve it just to get more people to take it. I want an approval only if it passes their standard approval process. Speeding that up where possible is fine, but generating a desired outcome simply to appease will make things worse in the long run. A number of people are having problems with these shots. Enough that they must go through a proper vetting process, however I understand that may involve years of observation and I realize we don’t have that kind of time. Hopefully they are being careful and putting people’s health over politics first.

    1. Correct Jeff, let’s get 2 year data and more documented through the FDA, including how it affects women who plan to bear children, review risk profiles of people under the age of 70 and transparent data.

      Ya know, be honest and not political?

    2. Sure thing, and make sure they also study all those long COVID patients who never seem to get included in those stats for those who who keep claiming that 99.4% of COVID patients “survive”.

      As though being left with tinnitus so bad you choose to kill yourself is “surviving COVID”.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In